Steven Innaimo

676 total citations
8 papers, 545 citations indexed

About

Steven Innaimo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Steven Innaimo has authored 8 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Steven Innaimo's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and HIV/AIDS drug development and treatment (3 papers). Steven Innaimo is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and HIV/AIDS drug development and treatment (3 papers). Steven Innaimo collaborates with scholars based in United States, United Kingdom and France. Steven Innaimo's co-authors include Richard J. Colonno, Robert Zahler, Gregory S. Bisacchi, Maria Seifer, David N. Standring, D. Taylor, Junius M. Clark, Eugene V. Genovesi, J. Kent Rinehart and Gregory Yamanaka and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Steven Innaimo

8 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Innaimo United States 7 399 342 227 110 87 8 545
Claire Pierra France 15 376 0.9× 374 1.1× 421 1.9× 258 2.3× 160 1.8× 37 763
Brent Korba United States 13 217 0.5× 134 0.4× 171 0.8× 143 1.3× 78 0.9× 22 410
Erika Cretton-Scott United States 8 207 0.5× 209 0.6× 234 1.0× 125 1.1× 46 0.5× 10 423
Carrie A. Rutkowski United States 11 138 0.3× 200 0.6× 295 1.3× 196 1.8× 135 1.6× 13 518
Darius Bilimoria Canada 10 171 0.4× 320 0.9× 220 1.0× 161 1.5× 55 0.6× 11 472
Keith Pietropaolo United States 12 190 0.5× 194 0.6× 211 0.9× 67 0.6× 34 0.4× 33 370
Dawn D. Parker United States 13 134 0.3× 145 0.4× 203 0.9× 154 1.4× 137 1.6× 22 498
Jeremy L. Clark United States 6 134 0.3× 170 0.5× 212 0.9× 148 1.3× 60 0.7× 9 343
Barbara Pacini Italy 8 110 0.3× 163 0.5× 191 0.8× 104 0.9× 89 1.0× 9 330
Margaret Gartland United States 9 156 0.4× 148 0.4× 201 0.9× 82 0.7× 27 0.3× 15 404

Countries citing papers authored by Steven Innaimo

Since Specialization
Citations

This map shows the geographic impact of Steven Innaimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Innaimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Innaimo more than expected).

Fields of papers citing papers by Steven Innaimo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Innaimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Innaimo. The network helps show where Steven Innaimo may publish in the future.

Co-authorship network of co-authors of Steven Innaimo

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Innaimo. A scholar is included among the top collaborators of Steven Innaimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Innaimo. Steven Innaimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Coupe, Nicholas, David J. Pinato, Justin Fairchild, et al.. (2023). IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 41(16_suppl). 2575–2575. 1 indexed citations
2.
Tang, Hong, Jamie T. Griffin, Steven Innaimo, Lois D. Lehman‐McKeeman, & Cyril Llamoso. (2013). The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 1(1). 51–8. 13 indexed citations
3.
Genovesi, Eugene V., D. Taylor, Maria Seifer, et al.. (2000). Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection. Antiviral Research. 48(3). 197–203. 12 indexed citations
4.
Yamanaka, Gregory, Steven Innaimo, Gregory S. Bisacchi, et al.. (1999). Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 43(1). 190–193. 87 indexed citations
5.
Genovesi, Eugene V., D. Taylor, Maria Seifer, et al.. (1999). Efficacy of the Carbocyclic 2′-Deoxyguanosine Nucleoside BMS-200475 in the Woodchuck Model of Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. 43(3). 726–726. 7 indexed citations
6.
Genovesi, Eugene V., D. Taylor, Maria Seifer, et al.. (1998). Efficacy of the Carbocyclic 2′-Deoxyguanosine Nucleoside BMS-200475 in the Woodchuck Model of Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. 42(12). 3209–3217. 94 indexed citations
7.
Innaimo, Steven, Maria Seifer, Gregory S. Bisacchi, et al.. (1997). Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrobial Agents and Chemotherapy. 41(7). 1444–1448. 220 indexed citations
8.
Bisacchi, Gregory S., Sam Chao, Jean‐Paul Daris, et al.. (1997). BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro. Bioorganic & Medicinal Chemistry Letters. 7(2). 127–132. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Pierra Breakdown of academic impact, for papers by Brent Korba Breakdown of academic impact, for papers by Erika Cretton-Scott Breakdown of academic impact, for papers by Carrie A. Rutkowski Breakdown of academic impact, for papers by Darius Bilimoria Breakdown of academic impact, for papers by Keith Pietropaolo Breakdown of academic impact, for papers by Dawn D. Parker Breakdown of academic impact, for papers by Jeremy L. Clark Breakdown of academic impact, for papers by Barbara Pacini Breakdown of academic impact, for papers by Margaret Gartland
Rankless by CCL
2026